Cargando…
Drug Resistance and Novel Therapeutic Approaches in Invasive Candidiasis
Candida species are the leading cause of invasive fungal infections worldwide and are associated with acute mortality rates of ~50%. Mortality rates are further augmented in the context of host immunosuppression and infection with drug-resistant Candida species. In this review, we outline antifungal...
Autores principales: | Murphy, Sarah E., Bicanic, Tihana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8713075/ https://www.ncbi.nlm.nih.gov/pubmed/34970504 http://dx.doi.org/10.3389/fcimb.2021.759408 |
Ejemplares similares
-
Vaccines against candidiasis: Status, challenges and emerging opportunity
por: Sahu, Satya Ranjan, et al.
Publicado: (2022) -
Development and Validation of a Risk Score for Predicting Invasive Candidiasis in Intensive Care Unit Patients by Incorporating Clinical Risk Factors and Lymphocyte Subtyping
por: Zhang, Jiahui, et al.
Publicado: (2022) -
Oral Microbiota Composition and Function Changes During Chronic Erythematous Candidiasis
por: Lyu, Xin, et al.
Publicado: (2021) -
Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy
por: Sun, Zhongwen, et al.
Publicado: (2023) -
Molecular association of Candida albicans and vulvovaginal candidiasis: focusing on a solution
por: David, Helma, et al.
Publicado: (2023)